CD133+ Brain Tumor-Initiating Cells Are Dependent on STAT3 Signaling to Drive Medulloblastoma Recurrence

Oncogene - United Kingdom
doi 10.1038/onc.2016.235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Stattic and Metformin Inhibit Brain Tumor Initiating Cells by Reducing STAT3-phosphorylation

Oncotarget
Oncology
2016English

Tumor-Initiating Cells in Malignant Brain Tumors

English

STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2014English

SPARC Expression Induces Cell Cycle Arrest via STAT3 Signaling Pathway in Medulloblastoma Cells

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2012English

MYC-regulated Mevalonate Metabolism Maintains Brain Tumor Initiating Cells

Cancer Research
Cancer ResearchOncology
2017English

CD133 Induces Tumour-Initiating Properties in HEK293 Cells

Tumor Biology
MedicineCancer Research
2012English

Generation of Prostate Tumor-Initiating Cells Is Associated With Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling

Cancer Research
Cancer ResearchOncology
2013English

Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

PLoS ONE
Multidisciplinary
2012English

TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice

Gastroenterology
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy